Applied DNA Sciences Inc (APDN)
3.63
-0.12
(-3.20%)
USD |
NASDAQ |
May 06, 16:00
3.63
0.00 (0.00%)
After-Hours: 20:00
Applied DNA Sciences Cash from Investing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.9247M |
| June 30, 2023 | -0.1618M |
| March 31, 2023 | -0.0543M |
| December 31, 2022 | 0.045M |
| September 30, 2022 | -0.2427M |
| June 30, 2022 | -0.0767M |
| March 31, 2022 | -0.0655M |
| December 31, 2021 | -0.1047M |
| September 30, 2021 | -0.9064M |
| June 30, 2021 | -0.5027M |
| March 31, 2021 | -0.81M |
| December 31, 2020 | -0.3295M |
| September 30, 2020 | -1.008M |
| June 30, 2020 | -0.0114M |
| March 31, 2020 | -0.0448M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.001M |
| June 30, 2019 | -0.0045M |
| March 31, 2019 | -0.0119M |
| December 31, 2018 | -0.0521M |
| September 30, 2018 | 0.0035M |
| June 30, 2018 | -0.066M |
| March 31, 2018 | -0.1552M |
| December 31, 2017 | -0.0483M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.0341M |
| June 30, 2017 | -0.0176M |
| March 31, 2017 | -0.051M |
| December 31, 2016 | -0.0426M |
| September 30, 2016 | -0.1471M |
| June 30, 2016 | -0.4724M |
| March 31, 2016 | -0.0941M |
| December 31, 2015 | -0.0661M |
| September 30, 2015 | -1.679M |
| June 30, 2015 | -0.2269M |
| March 31, 2015 | -0.2021M |
| December 31, 2014 | -0.0308M |
| September 30, 2014 | -0.0201M |
| June 30, 2014 | -0.0999M |
| March 31, 2014 | -0.0151M |
| December 31, 2013 | -0.0945M |
| September 30, 2013 | -0.4231M |
| June 30, 2013 | -0.7675M |
| March 31, 2013 | -0.0301M |
| December 31, 2012 | 0.00 |
| September 30, 2012 | -0.097M |
| June 30, 2012 | -0.0187M |
| March 31, 2012 | -0.0471M |
| December 31, 2011 | |
| September 30, 2011 | -0.0891M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.008M
Minimum
Sep 2020
0.045M
Maximum
Dec 2022
-0.2737M
Average
-0.0767M
Median
Jun 2022
Cash from Investing (Quarterly) Benchmarks
| Fonar Corp | -0.133M |
| XWELL Inc | 6.822M |
| ProPhase Labs Inc | -1.264M |
| Veracyte Inc | -2.497M |
| OncoCyte Corp | 0.241M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.758M |
| Cash from Financing (Quarterly) | -0.0351M |
| Free Cash Flow | -7.592M |
| Free Cash Flow Per Share (Quarterly) | -5.496 |
| Free Cash Flow to Equity (Quarterly) | -3.758M |
| Free Cash Flow to Firm (Quarterly) | -3.758M |
| Free Cash Flow Yield | -315.3% |